2. Gene
  3. St3gal5 - ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Gene

St3gal5 - ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus

Also known as Siat9

Gene ID: 83505 | Gene type: protein coding

About St3gal5

Summary

Predicted to enable lactosylceramide alpha-2,3-sialyltransferase activity. Predicted to be involved in protein glycosylation. Predicted to be located in Golgi membrane. Predicted to be integral component of membrane. Human ortholog(s) of this gene implicated in salt and pepper syndrome. Orthologous to human ST3GAL5 (ST3 beta-galactoside alpha-2,3-sialyltransferase 5). [provided by Alliance of Genome Resources, Apr 2022]

St3gal5 Products(4)

mRNA Protein Name
NM_001398712.1 NP_001385641.1 lactosylceramide alpha-2,3-sialyltransferase isoform 1
NM_001398713.1 NP_001385642.1 lactosylceramide alpha-2,3-sialyltransferase isoform 2
NM_001398714.1 NP_001385643.1 lactosylceramide alpha-2,3-sialyltransferase isoform 3
NM_031337.3 NP_112627.2 lactosylceramide alpha-2,3-sialyltransferase isoform 2
Protein Preferred Names Protein Names

lactosylceramide alpha-2,3-sialyltransferase

CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase

GM3 synthase

ST3Gal V

ST3GalV

ganglioside GM3 synthase

sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase)

sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sial

Related Agents

Clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-W013053 Dibenz[a,h]anthracene Inducer 98.0% Phase 3
Pre-clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-E70299 ST3 β-Gal α-2,3-Sialyltransferase 5 Inhibitor / Unkown
HY-RS13850 ST3GAL5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens St3gal5 NCBI NCBI:8869